CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Subacromial high volume infiltration +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03303001
NCT03303001N/ACompleted

Subacromial Injection of High Volume Versus Conventional Steroid Injection Guided by Ultrasound in Shoulder Pain. Randomized Controlled Trial

Universidad Autonoma de Nuevo Leon·interventional·Posted Oct 5, 2017·Updated Feb 2, 2021

In Brief

A clinical study evaluating Subacromial high volume infiltration and Subacromial conventional infiltration for Subacromial Bursitis and 2 related conditions. Completed, enrolled 22 participants across 2 sites.

Detailed Summary

The shoulder pain is commonly seeing in orthopedic consultation. Many patients was affected in activities of daily living and in laborer absent. One of the first treatment lines is the steroid infiltration for pain relieve, however in several times is only effective by a short period of time, and the symptoms usually appear again. One of the not known infiltration is the high volumen infiltration in subacromial space, this treatment appears to be an effective treatment for this patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesMexico
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 5, 2017
Enrollment StartOct 10, 2017
Primary CompletionMar 30, 2020
Study CompletionApr 30, 2020
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 8.7 years ago

Interventions

Subacromial high volume infiltrationprocedure

This group will receive a high volume dose of a mix of methylprednisolone (40 mg in 2 mL) plus ropivacaine at 7.5% plus simple lidocaine plus saline solution for a total of 50 mL

Subacromial conventional infiltrationprocedure

This group will receive a mix of solution of 2 mL of 40 mg of methylprednisolone plus 5 ml of ropivacaine at 7.5% plus 3 mL of lidocaine simple for a total of 10 ml